Articles From: Diana Shipping Inc. Announces Signing and Drawdown of a US$53.5 Million Term Loan Facility With BNP Paribas to DICK'S Sporting Goods Announces 10 Percent Increase in Quarterly Dividend


2014/12/22
ATHENS, Greece, Dec.
Sign-up for Diana Shipping Inc. Announces Signing and Drawdown of a US$53.5 Million Term Loan Facility With BNP Paribas investment picks
2014/12/9
ATHENS, Greece, Dec.
Sign-up for Diana Shipping Inc. Announces the Acquisition of a New-Building Capesize Dry Bulk Vessel investment picks
2015/1/2
ATHENS, Greece, Jan.
Sign-up for Diana Shipping Inc. Announces Time Charter Contract for m/v Houston With RWE investment picks
2015/1/27
ATHENS, Greece, Jan.
Sign-up for Diana Shipping Inc. Announces Time Charter Contract for m/v Melite With Glencore investment picks
2014/12/23
ATHENS, Greece, Dec.
Sign-up for Diana Shipping Inc. Announces Time Charter Contract for m/v Myrto With Glencore investment picks
2014/12/12
ATHENS, Greece, Dec.
Sign-up for Diana Shipping Inc. Announces Time Charter Contract for M/V New York With Clearlake investment picks
2014/12/4
ATHENS, Greece, Dec.
Sign-up for Diana Shipping Inc. Announces Time Charter Contract for M/V Salt Lake City With K Noble investment picks
2015/1/14
ATHENS, Greece, Jan.
Sign-up for Diana Shipping Inc. Announces Time Charter Contract for m/v Santa Barbara With RWE investment picks
2015/2/19
ATHENS, Greece, Feb.
Sign-up for Diana Shipping Inc. Announces Time Charter Contracts for m/v Semirio and m/v Sideris GS With Rio Tinto investment picks
2015/2/3
Diane Harris has been named editor of Money , it was announced today by Evelyn Webster, Executive Vice President, Time Inc. (NYSE:TIME). Harris will be the eighth editor of Money since the magazine was established in 1972.
Sign-up for Diane Harris Named Editor of Money investment picks
2014/12/11
MOUNTAIN VIEW, Calif.
Sign-up for Diario Medico Names ADASUVE® in its "Best Ideas of 2014" investment picks
2015/1/12
DIAXONHIT - Heart transplant test About AlloMap® AlloMap Molecular Testing is intended to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (ACR) at the time of testing in conjunction with standard clinical assessment.
Sign-up for DIAXONHIT announces that Strasbourg University Hospital will become its European Central Laboratory for processing the CareDx(r) AlloMap(r) heart transplant tests investment picks
2014/12/8
NEW YORK , Dec.
Sign-up for Dice Holdings Announces Appointment of Burton M. Goldfield to Board of Directors investment picks
2015/1/15
NEW YORK , Jan.
Sign-up for Dice Holdings Announces Appointment of Jim Friedlich to Board of Directors investment picks
2014/12/8
Big data sourcing tool brings fin tech talent to financial services hiring managers' fingertips NEW YORK , Dec.
Sign-up for Dice Holdings Launches Open Web™ with Finance Vertical investment picks
2014/12/15
NEW YORK , Dec.
Sign-up for Dice Holdings, Inc. Announces New $50 Million Stock Repurchase Program investment picks
2014/12/10
NEW YORK , Dec.
Sign-up for Dice Holdings, Inc. Announces Rule 10b5-1 Stock Trading Plans for Expiring Stock Options investment picks
2015/1/29
NEW YORK , Jan.
Sign-up for Dice Holdings, Inc. Reports Fourth Quarter and Full Year 2014 Results investment picks
2015/2/3
NEW YORK , Feb.
Sign-up for Dice Holdings, Inc. to Present at the Stifel 2015 Technology, Internet & Media Conference investment picks
2015/2/17
NEW YORK , Feb.
Sign-up for Dice Holdings, Inc. to Present at Upcoming Investor Events investment picks
2015/1/8
NEW YORK , Jan.
Sign-up for Dice Holdings, Inc. to Report Fourth Quarter and Full Year 2014 Results investment picks
2015/1/12
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi therapeutics, today announced that the United States Patent and Trademark Office (USPTO) issued to Dicerna Patent No.
Sign-up for Dicerna Announces Issuance of US Patent Providing Broad Coverage of DsiRNA-EX RNAi Payloads investment picks
2014/12/17
Dicerna Pharmaceuticals, Inc. (“Dicerna” or the “Company”) (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced the appointment of Theodore (Ted) T.
Sign-up for Dicerna Announces the Appointment of Theodore T. Ashburn, M.D., Ph.D. to Senior Vice President, Product Strategy and Operations, and Inducement Grant of Stock Options under NASDAQ Listing Rule 5635 (c)(4) investment picks
2015/2/2
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi therapeutics, today announced that the first patient has been dosed in a global Phase 1b/2 clinical trial of DCR-MYC, an investigational Dicer substrate short interfering RNA (DsiRNA) therapeutic, in patients with advanced hepatocellular carcinoma (HCC). This new trial expands the development program for DCR-MYC, which is also being studied in a Phase 1 clinical trial in patients with solid tumors and hematological malignancies.
Sign-up for Dicerna Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Clinical Trial of DCR-MYC, an Investigational RNAi Therapeutic Targeting the MYC Oncogene, in Patients with Advanced Hepatocellular Carcinoma investment picks
2015/1/12
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi therapeutics, today announced the presentation of new preclinical data on its Dicer substrate short interfering RNA (DsiRNA) therapeutics targeting MYC and β-catenin (CTNNB1) oncogenes in models of hepatocellular carcinoma (HCC) and colorectal cancer (CRC). The positive data, presented during a poster session on January 9 at MYC: From Biology to Therapy, a meeting of the American Association of Cancer Research (AACR) in La Jolla, Calif., provide additional insights into the parameters that impact the delivery and activity of DsiRNA therapeutics utilizing Dicerna’s proprietary EnCore™ lipid nanoparticle (LNP) technology in HCC and CRC tumor models.
Sign-up for Dicerna Pharmaceuticals Presents Positive Preclinical Data on its DsiRNA Therapeutics Targeting MYC and β-Catenin at AACR MYC: From Biology to Therapy Meeting investment picks
2014/12/15
Dicerna Pharmaceuticals, Inc .
Sign-up for Dicerna R&D Update Webcast Reminder investment picks
2015/2/4
Dicerna Pharmaceuticals, Inc .
Sign-up for Dicerna to Present at the 2015 Leerink Global Healthcare Conference investment picks
2015/2/10
The sporting goods retailer will focus on supporting the journey of U.S. Olympic and Paralympic hopefuls PITTSBURGH , Feb.
Sign-up for DICK'S Sporting Goods And The U.S. Olympic Committee Announce Partnership investment picks
2015/2/23
PITTSBURGH , Feb.
Sign-up for DICK'S Sporting Goods Announces 10 Percent Increase in Quarterly Dividend investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Diana Shipping Inc. Announces Signing and Drawdown of a US$53.5 Million Term Loan Facility With BNP Paribas to DICK'S Sporting Goods Announces 10 Percent Increase in Quarterly Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent